Navigation Links
China Cord Blood Corporation Announces Results of 2010 Annual General Meeting
Date:2/22/2011

HONG KONG, Feb. 22, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or "the Company"), the first and largest cord blood banking operator in China, today announced the results of its 2010 Annual General Meeting, which was held on February 18, 2011, in Hong Kong.

At the Annual General Meeting, shareholders

  • elected Albert Chen and Mark Chen to serve on the Board of Directors until the 2013 annual general meeting of the Company or until their respective successors are duly appointed and qualified;

  • ratified the appointment of KPMG as auditor of the Company for the financial year ending March 31, 2011, and authorized the directors to set the remuneration of the auditors; and

  • adopted the 2011 China Cord Blood Corporation Restricted Share Unit Scheme, or the "Incentive Plan," which has a mandate limit of granting rights to receive ordinary shares not exceeding 10.0% of the Company's issued and outstanding share capital, to directors, officers, employees and/or consultants of the Company and its subsidiaries and authorize directors to grant awards and allot and issue shares thereunder.

  • About China Cord Blood CorporationChina Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.  For more information, please contact:China Cord Blood CorporationMs. Joeling LawTel:
    +852-3605-8180Email: ir@chinacordbloodcorp.comICR, LLCIn New York: Ashley M. AmmonTel: +1-646-277-1227In Beijing: Wen Lei ZhengTel: +86-10-6583-7510
    '/>"/>

    SOURCE China Cord Blood Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. China Cord Blood Corporation to Announce Third Quarter Fiscal 2011 Financial Results
    2. China-Biotics to Report Fiscal Year 2011 Third Quarter Financial Results on February 9
    3. China-Biotics, Inc. Provides Preliminary FY2011Third Quarter Revenue
    4. Reportlinker Adds Industrial Biotechnology China News 1011
    5. Reportlinker Adds Financial Health of Biotechnology and Drugs Industry in India and China
    6. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on February 18, 2011
    7. China-Biotics, Inc. to Hold 2010 Annual Meeting of Stockholders on March 9, 2011
    8. China Cord Blood Corporation Announces Completion of Warrant Exchange
    9. China-Biotics Announces Redemption of $25 million in Senior Convertible Notes
    10. China Cord Blood Corporation Announces Participation at the 29th Annual J.P. Morgan Healthcare Conference
    11. PRA International Expert to Speak at China Drug Safety Summit
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/18/2017)... PA (PRWEB) , ... January 18, 2017 , ... ... operations again at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency ... engaging panel discussions to examine vital clinical research issues such as trial performance ...
    (Date:1/18/2017)... ... ... Thirty-six startup companies in University City and Center City have been awarded ... Development in 2016 as part of the Keystone Innovation Zone (KIZ) Tax Credit Program. ... represent the highest number of awards to the largest number of companies in the ...
    (Date:1/18/2017)... Jan. 18, 2017  Caris Life Sciences, a ... Foundation, the largest private funder of pancreatic cancer ... evaluating the impact of immunotherapy in the treatment ... enrollment services to identify potential trial candidates based ... treating physicians and study investigators. The Lustgarten Foundation ...
    (Date:1/17/2017)... ... January 17, 2017 , ... LGC Maine ... its VALIDATE® SP2 calibration verification / linearity test kit. VALIDATE® SP2 evaluates Albumin, ... VALIDATE® SP2 kit is prepared using the CLSI recommended “equal delta” method for ...
    Breaking Biology Technology:
    (Date:1/13/2017)... N.Y. , Jan. 13, 2017 ... technology solutions for the homecare industry, including Electronic ... homecare industry expert, Justin Jugs, as Senior Vice ... more than 15 years of homecare experience to ... in developing strategic plans to align Sandata,s suite ...
    (Date:1/12/2017)... PORTLAND, Oregon and PUNE, India , January 12, 2017 ... Technology Market: Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology ... CAGR of 19.4% from 2016 to 2022. Continue Reading ... ... ...
    (Date:1/6/2017)... Jan. 6, 2017  Privately-held CalciMedica, Inc., announced ... healthy volunteers of a novel calcium release-activated calcium ... pancreatitis. Acute pancreatitis, sudden painful ... disorder, but can be very serious.  In severe cases ... where extended hospital stays, time in the ICU ...
    Breaking Biology News(10 mins):